We observed that ADAM12 and CYP1B1 downregulation has a deep impact on the proliferative ability and the invasiveness of RCC cells, pointing to a critical role of these genes in regulating tumor–stroma interplay and fostering kidney cancer in obese patients. Here, ADAM12 is linked to neoplasm.